Lieping Chen

95.2k citations
366 papers · 79.1k · 29 hit papers · h-index 119

Impact in

  • Oncology top 0.01%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
  • Immunology top 0.01%
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses
    • Immune cells in cancer

Papers in

    • T-cell and B-cell Immunology 133
    • Immunotherapy and Immune Responses 95
    • Immune Cell Function and Interaction 9
    • Immune cells in cancer 8
    • Immune Response and Inflammation 6
    • Cancer Immunotherapy and Biomarkers 133

Lieping Chen

362 papers receiving 77.3k citations

Lieping Chen's Hit Papers

Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach 2025 · 48 citations
480+4+8Years since publication5001k1.5k2k

Peers

Lieping Chen
Comparison fields: 5 of 149
  • Oncology 42.1k
  • Immunology 22.9k
  • Otorhinolaryngology 1.1k
  • Cancer Research 2.6k
  • Hepatology 1.6k
Replace James Patrick Allison with:
James Patrick Allison United States
Suzanne Louise Topalian United States
Wolf H. Fridman France
Ton N. Schumacher Netherlands
Mark John Smyth Australia
Dmitry I. Gabrilovich United States
Arlene H. Sharpe United States
Weiping Zou United States
Charles G. Drake United States
Jeffrey S. Weber United States
Lieping Chen relative to James Patrick Allison United States James Patrick Allison's profile →
Citations per field
00.5×1.5×1.8×
James Patrick Allison · 1×
Citations per year

Countries citing papers authored by Lieping Chen

Since Specialization
Citations

This map shows the geographic impact of Lieping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lieping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lieping Chen more than expected).

Fields of papers citing papers by Lieping Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lieping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lieping Chen. The network helps show where Lieping Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Lieping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lieping Chen Line = papers co-authored together Lieping Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 366 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Hit paper breakdown →
201210619
2
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
Hit paper breakdown →
20044365
3
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Hit paper breakdown →
20024289
4
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Hit paper breakdown →
20102594
5
Molecular mechanisms of T cell co-stimulation and co-inhibition
Hit paper breakdown →
20132512
6
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
Hit paper breakdown →
19992209
7
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy
Hit paper breakdown →
20142067
8
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Hit paper breakdown →
20162055
9
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Hit paper breakdown →
20121856
10
Inhibitory B7-family molecules in the tumour microenvironment
Hit paper breakdown →
20081400
11
Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
Hit paper breakdown →
20151243
12
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Hit paper breakdown →
20181203
13
Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity
Hit paper breakdown →
20031127
14
Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity
Hit paper breakdown →
20041088
15
Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
Hit paper breakdown →
1992945
16
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
Hit paper breakdown →
2001898
17
Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity
Hit paper breakdown →
2005852
18
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Hit paper breakdown →
2014839
19
Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
Hit paper breakdown →
1997797
20
Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
Hit paper breakdown →
2018730

About Lieping Chen

Lieping Chen is a scholar working on Immunology, Oncology, Hematology, Pathology and Forensic Medicine and Epidemiology, having authored 366 papers that have together received 79.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (133 papers), T-cell and B-cell Immunology (133 papers), Immunotherapy and Immune Responses (95 papers), Hematopoietic Stem Cell Transplantation (12 papers), Immune Cell Function and Interaction (9 papers), Immune cells in cancer (8 papers), Immune Response and Inflammation (6 papers) and Diabetes and associated disorders (6 papers). The work is most often cited by research in Oncology (42.1k citations), Immunology (22.9k citations), Otorhinolaryngology (1.1k citations), Cancer Research (2.6k citations) and Hepatology (1.6k citations). Lieping Chen has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Dallas B. Flies, Koji Tamada, Gefeng Zhu, Weiping Zou, Haidong Dong, Miguel F. Sanmamed, Drew M. Pardoll, Xue Na Han, Jedd D. Wolchok and Scott Eric Strome. Their work appears in journals such as The Journal of Immunology, Blood, Clinical Cancer Research, Journal of Clinical Investigation and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact